Profil
Daniel S.
Grosu is the founder of PetDx, Inc. He previously worked at Sequenom, Inc. as the Chief Medical Officer & Senior Vice President from 2015 to 2016.
Before that, he held the position of Chief Medical Officer & Vice President at Illumina, Inc. Dr. Grosu obtained an MBA from the University of Oxford and a doctorate from Saint Louis University School of Medicine.
Postes actifs de Daniel S. Grosu
| Sociétés | Poste | Début |
|---|---|---|
PetDx, Inc.
 PetDx, Inc. BiotechnologyHealth Technology PetDx, Inc. operates as a biotechnology company. It offers cancer detection services. The company is headquartered in San Diego, CA. | Founder | - |
Anciens postes connus de Daniel S. Grosu
| Sociétés | Poste | Fin |
|---|---|---|
| SEQUENOM, INC. | Chief Tech/Sci/R&D Officer | 01/10/2016 |
| ILLUMINA, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Daniel S. Grosu
| University of Oxford | Masters Business Admin |
| Saint Louis University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sequenom, Inc.
 Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
PetDx, Inc.
PetDx, Inc. BiotechnologyHealth Technology PetDx, Inc. operates as a biotechnology company. It offers cancer detection services. The company is headquartered in San Diego, CA. | Health Technology |
